VTVT — vTv Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $64.63m
- $38.35m
- $1.02m
Annual cashflow statement for vTv Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -12.8 | -17.7 | -25.1 | -26 | -22.7 |
| Depreciation | |||||
| Non-Cash Items | -2.59 | -1.7 | 3.56 | 2.4 | 2.75 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2.71 | 0.035 | 5.4 | 4.39 | -5.44 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -18 | -19.3 | -16 | -19.1 | -25.3 |
| Capital Expenditures | 0 | 0 | -0.021 | 0 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 0 | — | 4.4 | 0 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | 0 | 0 | -0.021 | 4.4 | 0 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 19.5 | 27 | 14.8 | 12 | 52.6 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.47 | 7.67 | -1.29 | -2.68 | 27.3 |